Tags

Type your tag names separated by a space and hit enter

Managing rhinitis: Strategies for improved patient outcomes.
Allergy Asthma Proc. 2008 Jul-Aug; 29(4):349-57.AA

Abstract

Allergic rhinitis affects more than 40 million Americans, with estimated costs reaching $5.3 billion annually. The global impact includes negative effects on quality of life (QOL), sleep, diminished work productivity, and exacerbation of comorbid conditions. An accurate diagnosis of allergic or nonallergic rhinitis is needed before selecting optimal treatment, which can include antihistamines, decongestants, intranasal corticosteroids, immunotherapy, and anticholinergics. It is also important to understand that pharmacologic properties of these different interventions may affect patient satisfaction, compliance, and overall clinical response. This article reviews currently available therapies for allergic rhinitis with a focus on improving patient outcomes.

Authors+Show Affiliations

Allergy and Asthma Associates of Southern California, Mission Viejo, California 92691, USA. warnercarr@hotmail.comNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

18702880

Citation

Carr, Warner W., et al. "Managing Rhinitis: Strategies for Improved Patient Outcomes." Allergy and Asthma Proceedings, vol. 29, no. 4, 2008, pp. 349-57.
Carr WW, Nelson MR, Hadley JA. Managing rhinitis: Strategies for improved patient outcomes. Allergy Asthma Proc. 2008;29(4):349-57.
Carr, W. W., Nelson, M. R., & Hadley, J. A. (2008). Managing rhinitis: Strategies for improved patient outcomes. Allergy and Asthma Proceedings, 29(4), 349-57. https://doi.org/10.2500/aap.2008.29.3145
Carr WW, Nelson MR, Hadley JA. Managing Rhinitis: Strategies for Improved Patient Outcomes. Allergy Asthma Proc. 2008 Jul-Aug;29(4):349-57. PubMed PMID: 18702880.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Managing rhinitis: Strategies for improved patient outcomes. AU - Carr,Warner W, AU - Nelson,Michael R, AU - Hadley,James A, PY - 2008/8/16/pubmed PY - 2008/12/17/medline PY - 2008/8/16/entrez SP - 349 EP - 57 JF - Allergy and asthma proceedings JO - Allergy Asthma Proc VL - 29 IS - 4 N2 - Allergic rhinitis affects more than 40 million Americans, with estimated costs reaching $5.3 billion annually. The global impact includes negative effects on quality of life (QOL), sleep, diminished work productivity, and exacerbation of comorbid conditions. An accurate diagnosis of allergic or nonallergic rhinitis is needed before selecting optimal treatment, which can include antihistamines, decongestants, intranasal corticosteroids, immunotherapy, and anticholinergics. It is also important to understand that pharmacologic properties of these different interventions may affect patient satisfaction, compliance, and overall clinical response. This article reviews currently available therapies for allergic rhinitis with a focus on improving patient outcomes. SN - 1088-5412 UR - https://www.unboundmedicine.com/medline/citation/18702880/Managing_rhinitis:_Strategies_for_improved_patient_outcomes_ L2 - https://www.ingentaconnect.com/openurl?genre=article&issn=1088-5412&volume=29&issue=4&spage=349&aulast=Carr DB - PRIME DP - Unbound Medicine ER -